Related Experiment Video
Updated: Jun 6, 2026
09:29
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
Fluoxetine treatment induces EAAT2 expression in rat brain
1Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, P.O. Box 122120, 68072 Mannheim, Germany. mathias.zink@zi-mannheim.de
Journal of Neural Transmission (Vienna, Austria : 1996)
|December 17, 2010
Summary
Fluoxetine treatment significantly increased excitatory amino acid transporter 2 (EAAT2) expression in rat brains, suggesting a role for this glutamate transporter in depression treatment. Other antidepressants did not show significant effects.
Area of Science:
- Neuroscience
- Neurobiology of Depression
- Glutamatergic Neurotransmission
Background:
- Depression is linked to synaptic pathology and altered glutamatergic neurotransmission.
- Reduced expression of glutamate transporters, particularly excitatory amino acid transporter 2 (EAAT2), is observed in depression.
Purpose of the Study:
- To investigate the impact of antidepressant treatments on EAAT2 expression in a rat model.
- To explore the relationship between EAAT2 regulation and antidepressant efficacy.
Main Methods:
- Male Sprague-Dawley rats received daily injections of desipramine, fluoxetine, tranylcypromine, or saline for 14 days.
- EAAT2 expression was quantified using semi-quantitative in situ hybridization with a (35)S-labeled cRNA probe.
Main Results:
- Fluoxetine treatment significantly increased EAAT2 expression in hippocampal and cortical regions compared to controls.
- Desipramine and tranylcypromine did not produce significant changes in EAAT2 expression.
Conclusions:
- Increased EAAT2 expression induced by fluoxetine may help balance glutamatergic neurotransmission in depression.
- Findings support the glutamatergic theory of depression and highlight EAAT2 as a potential therapeutic target.
